Anifrolumab May Help Prevent Organ Damage in Patients With Systemic Lupus Erythematosus
Anifrolumab exhibited a high retention rate, effectively improved disease activity, and reduced glucocorticoid (GC) doses among patients with systemic lupus…
Anifrolumab exhibited a high retention rate, effectively improved disease activity, and reduced glucocorticoid (GC) doses among patients with systemic lupus…
As Americans head into the fourth holiday season with the COVID-19 virus, just over half of adults (51%) said they…
Wastewater surveillance performed during the COVID-19 pandemic yielded useful information on respiratory viruses circulating in the community, including RSV, influenza,…
Finerenone may prevent pneumonia and COVID-19 in patients with chronic kidney disease (CKD) and type 2 diabetes, according to a…
An Emergency Use Authorization (EUA) request has been submitted to the US Food and Drug Administration (FDA) for the adjuvanted…
Patients with advanced chronic kidney disease (CKD) have increased risks for hospitalization and death after COVID-19 infection. Yet PaxlovidTM (nirmatrelvir…
State-licensed pharmacists can now prescribe Paxlovid (nirmatrelvir tablets co-packaged with ritonavir tablets) with certain limitations to eligible patients, according to…
Good news for people with food allergies — having a food allergy cuts your risk of being infected with COVID-19…
The Food and Drug Administration (FDA)’s Vaccines and Related Biological Products Advisory Committee voted 21 to 0 (with 1 abstention)…
Post-COVID lung disease includes 3 different subtypes or subgroups that potentially require separate and different management, according to a study…